Table 1.
Phenotype | Reference | |
---|---|---|
Mediobasal hypothalamus KIF3A and IFT 88 knockdown |
↑ food intake | |
↓ energy expenditure | [32] | |
↓ anorexigenic effect of ICV injections of leptin/insulin/glucose | ||
| ||
Systemic deletion KIF3A TG737 (IFT88) |
↑ body weight | |
↑ food intake | ||
Hyperleptinemia | [2] | |
Hyperinsulinemia | ||
Fasting hyperglycemia | ||
| ||
BBS knockout models Bbs2 −/− Bbs4 −/− Bbs6 −/− |
↑ body weight | |
↑ food intake | [33] | |
↓ locomotor activity | ||
Hyperleptinemia | ||
| ||
IFT88 Δ/Δ mice | ↑ body weight | [34] |
Hyperleptinemia | ||
| ||
CEP19 knockout | ↑ body weight | |
Hyperphagia | [35] | |
↓ glucose tolerance | ||
Insulin resistance | ||
| ||
ANK RD26 knockout | ↑ Body weight | |
Hyperphagia | [36] | |
MCHR1 and SST3R mislocalization in the hypothalamus |
||
| ||
TTC21B knockout | ↑ body weight (fat mass) | |
Hyperleptinemia | [37] | |
Hyperinsulinemia | ||
↓ glucose tolerance | ||
| ||
Rpgrip 1L +/− | ↑ body weight (fat mass, lean mass) |
|
Leptin resistance | [38] | |
Altered production of hypothalamic neuropeptides | ||
| ||
POMC-specific KIF3A KO |
↑ body weight | |
↑ food intake | [2] | |
Hyperleptinemia | ||
Hyperinsulinemia |